SCHEMBL16740198

SCHEMBL16740198

Cc1nc2ccc(O)cn2c1-c1cc(C#N)cc(Nc2ccc(C(F)(F)F)cc2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK1D P48730 2/20 0.39
▸ CSNK1G2 P78368 1/20 0.39
▸ USP7 Q93009 1/20 0.37
▸ PRKD3 O94806 1/20 0.37
▸ MAP4K4 O95819 1/20 0.37
▸ PIM1 P11309 1/20 0.37
▸ RPS6KB1 P23443 1/20 0.37
▸ CDK2 P24941 1/20 0.37
▸ FLT4 P35916 1/20 0.37
▸ FLT3 P36888 1/20 0.37
▸ MAPK8 P45983 1/20 0.37
▸ MAPK9 P45984 1/20 0.37
▸ GSK3A P49840 1/20 0.37
▸ GSK3B P49841 1/20 0.37
▸ CSNK2A1 P68400 1/20 0.37
▸ DYRK1A Q13627 1/20 0.37
▸ TAOK1 Q7L7X3 1/20 0.37
▸ PIM3 Q86V86 1/20 0.37
▸ PRKD2 Q9BZL6 1/20 0.37
▸ HIPK2 Q9H2X6 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16747966 0.90 CSNK1D (0.40) CSNK1DCSNK1G2TRPA1ABCG2ABCB1
SCHEMBL16747906 0.88 MCHR1 (0.42) CSNK1DPRKD3MAP4K4PIM1RPS6KB1
SCHEMBL16739896 0.87 GALR2 (0.44) CSNK1DCSNK1G2GSK3BTRPA1ABCG2
SCHEMBL16740402 0.83 TRPV1 (0.38) CSNK1DCSNK1G2CDK2ABCG2AGPAT2
SCHEMBL16739987 0.82 KCNH2 (0.41) CSNK1DUSP7PRKD3MAP4K4PIM1
SCHEMBL16747942 0.81 AGPAT2 (0.37) CSNK1DCSNK1G2TRPA1ABCG2AGPAT2
SCHEMBL16740141 0.79 SLC2A1 (0.42) CSNK1DCSNK1G2CDK2GSK3BTRPA1
SCHEMBL16740159 0.79 TRPA1 (0.39) CSNK1DCSNK1G2TRPA1ABCG2AGPAT2
SCHEMBL16740225 0.79 BMI1 (0.36) CSNK1DCSNK1G2AGPAT2DHODHGALR2
SCHEMBL16740344 0.78 GALR2 (0.44) DHODHMCHR1GALR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160280685-A1 SUBSTITUTED PYRIDINE AND PYRAZINE BMI-1 INHIBITORS PTC THERAPEUTICS, INC. 2016-09-29 — — US claimed
EP-3071553-A1 SUBSTITUTED PYRIDINE AND PYRAZINE BMI-1 INHIBITORS PTC Therapeutics, Inc. (US) 2016-09-28 — — EP claimed
WO-2015076800-A1 SUBSTITUTED PYRIDINE AND PYRAZINE BMI-1 INHIBITORS PTC THERAPEUTICS, INC. (US) 2015-05-28 — — WO claimed
US-10584115-B2 Substituted pyridine and pyrazine BMI-1 inhibitors PTC THERAPEUTICS, INC. (US) 2020-03-10 — — US disclosed
US-20160280685-A1 SUBSTITUTED PYRIDINE AND PYRAZINE BMI-1 INHIBITORS PTC THERAPEUTICS, INC. 2016-09-29 — — US disclosed
US-20160280685-A1 SUBSTITUTED PYRIDINE AND PYRAZINE BMI-1 INHIBITORS PTC THERAPEUTICS, INC. 2016-09-29 — — US disclosed
US-20160280685-A1 SUBSTITUTED PYRIDINE AND PYRAZINE BMI-1 INHIBITORS PTC THERAPEUTICS, INC. 2016-09-29 — — US disclosed
WO-2015076800-A1 SUBSTITUTED PYRIDINE AND PYRAZINE BMI-1 INHIBITORS PTC THERAPEUTICS, INC. (US) 2015-05-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160280685-A1 SUBSTITUTED PYRIDINE AND PYRAZINE BMI-1 INHIBITORS BMI1, BAZ2A, BAZ2B CSNK1D 3894/4885CSNK1G2 2734/4885USP7 1481/4885
US-10584115-B2 Substituted pyridine and pyrazine BMI-1 inhibitors BMI1, BAZ2A, BAZ2B CSNK1D 3894/4885CSNK1G2 2734/4885USP7 1481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback